Nutrien (NYSE:NTR) Releases Earnings Results, Misses Estimates By $0.11 EPS

Nutrien (NYSE:NTR) released its quarterly earnings data on Wednesday. The company reported $0.76 earnings per share for the quarter, missing the consensus estimate of $0.87 by ($0.11), Zacks reports. Nutrien had a return on equity of 7.54% and a net margin of 6.79%.

Nutrien Price Performance

Shares of NYSE NTR traded up $0.51 during trading hours on Wednesday, hitting $70.37. 2,552,595 shares of the stock were exchanged, compared to its average volume of 2,987,601. Nutrien has a 1-year low of $45.78 and a 1-year high of $73.55. The company has a market cap of $33.88 billion, a PE ratio of 18.97 and a beta of 0.73. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.89 and a current ratio of 1.41. The company’s fifty day simple moving average is $65.62 and its two-hundred day simple moving average is $60.42.

Analysts Set New Price Targets

A number of research firms have recently issued reports on NTR. Weiss Ratings restated a “hold (c)” rating on shares of Nutrien in a research note on Monday, December 29th. TD Securities restated a “buy” rating on shares of Nutrien in a report on Tuesday. Mizuho upped their target price on Nutrien from $65.00 to $68.00 and gave the company a “neutral” rating in a research report on Friday, January 16th. Zacks Research raised Nutrien from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 27th. Finally, Oppenheimer restated an “outperform” rating on shares of Nutrien in a research note on Tuesday, January 27th. Two analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $66.69.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of NTR. Sfam LLC bought a new stake in shares of Nutrien during the 4th quarter valued at approximately $37,000. Geneos Wealth Management Inc. grew its position in Nutrien by 42.4% during the 2nd quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock worth $43,000 after acquiring an additional 219 shares during the last quarter. Fulcrum Asset Management LLP acquired a new position in Nutrien in the 3rd quarter worth about $46,000. Acadian Asset Management LLC acquired a new position in Nutrien in the 1st quarter worth about $54,000. Finally, Arax Advisory Partners raised its position in Nutrien by 23.5% in the fourth quarter. Arax Advisory Partners now owns 1,525 shares of the company’s stock valued at $94,000 after purchasing an additional 290 shares during the last quarter. Institutional investors own 63.10% of the company’s stock.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.